Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 3Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rheumatic Diseases 1Neoplasms 1HIV Infections 1Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × halofantrine × Clear all
NCT02296255 2014-11-20

Effect of HPV Vaccination on Women Aged 25 Years

Cancer Prevention and Research Institute, Italy

Phase 4 Completed
832 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01894269 2013-07-23

Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01022905 2010-03-01

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients

University Hospital, Geneva

Phase 4 Completed
1,141 enrolled

Neoplasms, Rheumatic Diseases, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡